New formulations that enhance bioavailability, optimize drug-delivery profiles, reduce dosing frequency, or improve patient experience have the potential to deliver quicker returns on investments than developing a completely new drug…
Written by Adeline Siew, the article has been published in Pharmaceutical Technology, Volume 38, Issue 10, pages 24–30 Oct 2, 2015.